相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Contrast-induced nephropathy in CT: incidence, risk factors and strategies for prevention
Shu Min Tao et al.
EUROPEAN RADIOLOGY (2016)
Randomized clinical trial of chemoembolization plus radiofrequency ablation versus partial hepatectomy for hepatocellular carcinoma within the Milan criteria
H. Liu et al.
BRITISH JOURNAL OF SURGERY (2016)
Comparison of hepatocellular carcinoma in Eastern versus Western populations
Su Pin Choo et al.
CANCER (2016)
Population Attributable Fractions of Risk Factors for Hepatocellular Carcinoma in the United States
Oxana V. Makarova-Rusher et al.
CANCER (2016)
Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma
Riad Salem et al.
GASTROENTEROLOGY (2016)
International trends in liver cancer incidence, overall and by histologic subtype, 1978-2007
Jessica L. Petrick et al.
INTERNATIONAL JOURNAL OF CANCER (2016)
Future of Hepatocellular Carcinoma Incidence in the United States Forecast Through 2030
Jessica L. Petrick et al.
JOURNAL OF CLINICAL ONCOLOGY (2016)
Early occurrence and recurrence of hepatocellular carcinoma in HCV-related cirrhosis treated with direct-acting antivirals
Fabio Conti et al.
JOURNAL OF HEPATOLOGY (2016)
Intention to treat outcome of T1 hepatocellular carcinoma with the wait and not ablate approach until meeting T2 criteria for liver transplant listing
Neil Mehta et al.
LIVER TRANSPLANTATION (2016)
Imaging Outcomes of Liver Imaging Reporting and Data System Version 2014 Category 2, 3, and 4 Observations Detected at CT and MR Imaging
Masahiro Tanabe et al.
RADIOLOGY (2016)
Update on Biomarkers of Hepatocellular Carcinoma
Roongruedee Chaiteerakij et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2015)
Contrast-enhanced ultrasound for the differentiation of small atypical hepatocellular carcinomas from dysplastic nodules in cirrhosis
Seung Kak Shin et al.
DIGESTIVE AND LIVER DISEASE (2015)
SEARCH: A Phase III, Randomized, Double-Blind, Placebo-Controlled Trial of Sorafenib Plus Erlotinib in Patients With Advanced Hepatocellular Carcinoma
Andrew X. Zhu et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Linifanib Versus Sorafenib in Patients With Advanced Hepatocellular Carcinoma: Results of a Randomized Phase III Trial
Calin Cainap et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
Statin and the risk of hepatocellular carcinoma and death in a hospital-based hepatitis B-infected population: A propensity score landmark analysis
John Chen Hsiang et al.
JOURNAL OF HEPATOLOGY (2015)
Comparison of Chemoembolization with and without Radiation Therapy and Sorafenib for Advanced Hepatocellular Carcinoma with Portal Vein Tumor Thrombosis: A Propensity Score Analysis
Gi-Ae Kim et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2015)
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial
Jordi Bruix et al.
LANCET ONCOLOGY (2015)
Pilot randomized trial of selective internal radiation therapy vs. chemoembolization in unresectable hepatocellular carcinoma
Frank T. Kolligs et al.
LIVER INTERNATIONAL (2015)
Downstaging hepatocellular carcinoma: A systematic review and pooled analysis
Neehar D. Parikh et al.
LIVER TRANSPLANTATION (2015)
Liver Imaging Reporting and Data System with MR Imaging: Evaluation in Nodules 20 mm or Smaller Detected in Cirrhosis at Screening US
Anna Darnell et al.
RADIOLOGY (2015)
Transcatheter Arterial Chemoembolization Plus Radiotherapy Compared With Chemoembolization Alone for Hepatocellular Carcinoma A Systematic Review and Meta-analysis
Ya Ruth Huo et al.
JAMA ONCOLOGY (2015)
A comparative study between sorafenib and hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma with portal vein tumor thrombosis
Do Seon Song et al.
JOURNAL OF GASTROENTEROLOGY (2015)
Peretinoin after curative therapy of hepatitis C-related hepatocellular carcinoma: a randomized double-blind placebo-controlled study
Kiwamu Okita et al.
JOURNAL OF GASTROENTEROLOGY (2015)
Prognostic Relevance of Objective Response According to EASL Criteria and mRECIST Criteria in Hepatocellular Carcinoma Patients Treated with Loco-Regional Therapies: A Literature-Based Meta-Analysis
Bruno Vincenzi et al.
PLOS ONE (2015)
Transarterial chemoembolization: Evidences from the literature and applications in hepatocellular carcinoma patients
Antonio Facciorusso et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
Current systemic treatment of hepatocellular carcinoma: A review of the literature
Kai-Wen Chen et al.
WORLD JOURNAL OF HEPATOLOGY (2015)
Overall survival in response to sorafenib versus radiotherapy in unresectable hepatocellular carcinoma with major portal vein tumor thrombosis: propensity score analysis
Takahide Nakazawa et al.
BMC GASTROENTEROLOGY (2014)
Partial hepatectomy vs. transcatheter arterial chemoembolization for resectable multiple hepatocellular carcinoma beyond Milan criteria: A RCT
Lei Yin et al.
JOURNAL OF HEPATOLOGY (2014)
Clinical and economical impact of 2010 AASLD guidelines for the diagnosis of hepatocellular carcinoma
Matteo Angelo Manini et al.
JOURNAL OF HEPATOLOGY (2014)
Early Detection, Curative Treatment, and Survival Rates for Hepatocellular Carcinoma Surveillance in Patients with Cirrhosis: A Meta-analysis
Amit G. Singal et al.
PLOS MEDICINE (2014)
A meta-analysis of adjuvant therapy after potentially curative treatment for hepatocellular carcinoma
Jun Wang et al.
CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2013)
Tumor biology and pre-transplant locoregional treatments determine outcomes in patients with T3 hepatocellular carcinoma undergoing liver transplantation
Peter T. W. Kim et al.
CLINICAL TRANSPLANTATION (2013)
Long-term effectiveness of resection and radiofrequency ablation for single hepatocellular carcinoma ≤3 cm. Results of a multicenter Italian survey
Maurizio Pompili et al.
JOURNAL OF HEPATOLOGY (2013)
Effect and Safety of Interferon for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis
Liping Zhuang et al.
PLOS ONE (2013)
Characterization of Primary and Recurrent Nodules in Liver Cirrhosis Using Contrast-Enhanced Ultrasound: Which Vascular Criteria Should Be Adopted?
S. Leoni et al.
ULTRASCHALL IN DER MEDIZIN (2013)
Risk factors for liver transplant waitlist dropout in patients with hepatocellular carcinoma
Sang-Jae Park et al.
CLINICAL TRANSPLANTATION (2012)
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma according to baseline status: Subset analyses of the phase III Sorafenib Asia-Pacific trial
Ann-Lii Cheng et al.
EUROPEAN JOURNAL OF CANCER (2012)
Accuracy and disagreement of computed tomography and magnetic resonance imaging for the diagnosis of small hepatocellular carcinoma and dysplastic nodules: Role of biopsy
Thomas Serste et al.
HEPATOLOGY (2012)
A randomized controlled trial of radiofrequency ablation and surgical resection in the treatment of small hepatocellular carcinoma
Kai Feng et al.
JOURNAL OF HEPATOLOGY (2012)
Non-invasive diagnosis of hepatocellular carcinoma ≤2 cm in cirrhosis. Diagnostic accuracy assessing fat, capsule and signal intensity at dynamic MRI
Jordi Rimola et al.
JOURNAL OF HEPATOLOGY (2012)
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial
Jordi Bruix et al.
JOURNAL OF HEPATOLOGY (2012)
Recommendations for liver transplantation for hepatocellular carcinoma: an international consensus conference report
Pierre-Alain Clavien et al.
LANCET ONCOLOGY (2012)
Increasing Prevalence of HCC and Cirrhosis in Patients With Chronic Hepatitis C Virus Infection
Fasiha Kanwal et al.
GASTROENTEROLOGY (2011)
Indeterminate 1-2-cm Nodules Found on Hepatocellular Carcinoma Surveillance: Biopsy for All, Some, or None?
Korosh Khalili et al.
HEPATOLOGY (2011)
Management of Hepatocellular Carcinoma: An Update
Jordi Bruix et al.
HEPATOLOGY (2011)
CURRENT CONCEPTS Hepatocellular Carcinoma
Hashem B. El-Serag
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Analysis of Gadobenate Dimeglumine-enhanced MR Findings for Characterizing Small (1-2-cm) Hepatic Nodules in Patients at High Risk for Hepatocellular Carcinoma
Tae Kyoung Kim et al.
RADIOLOGY (2011)
The Impact of Vascular and Nonvascular Findings on the Noninvasive Diagnosis of Small Hepatocellular Carcinoma Based on the EASL and AASLD Criteria
Simona Leoni et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
A Randomized Trial Comparing Radiofrequency Ablation and Surgical Resection for HCC Conforming to the Milan Criteria
Jiwei Huang et al.
ANNALS OF SURGERY (2010)
The diagnostic and economic impact of contrast imaging techniques in the diagnosis of small hepatocellular carcinoma in cirrhosis
Angelo Sangiovanni et al.
GUT (2010)
The place of downstaging for hepatocellular carcinoma
Christian Toso et al.
JOURNAL OF HEPATOLOGY (2010)
Value of Delayed Hypointensity and Delayed Enhancing Rim in Magnetic Resonance Imaging Diagnosis of Small Hepatocellular Carcinoma in the Cirrhotic Liver
Asra S. Khan et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2010)
Small nodules (1-2 cm) in liver cirrhosis: Characterization with contrast-enhanced ultrasound
Hyun-Jung Jang et al.
EUROPEAN JOURNAL OF RADIOLOGY (2009)
Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial
Ann-Lii Cheng et al.
LANCET ONCOLOGY (2009)
Nephrogenic Systemic Fibrosis: History and Epidemiology
Henrik S. Thomsen
RADIOLOGIC CLINICS OF NORTH AMERICA (2009)
Small hypervascular hepatocellular carcinoma: Limited value of portal and delayed phases on dynamic magnetic resonance imaging
J. S. Yu et al.
ACTA RADIOLOGICA (2008)
Liver and intestine transplantation in the United States, 1997-2006
R. B. Freeman et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Bridging Locoregional Therapy for Hepatocellular Carcinoma Prior to Liver Transplantation
Jason T. Heckman et al.
ANNALS OF SURGICAL ONCOLOGY (2008)
Clinical implication of small (<20 mm) enhancing hepatic nodules observed only during three-dimensional gadobenate dimeglumine-enhanced hepatic arterial-phase MRI of the hepatitis B virus-induced mild cirrhosis
Young Kon Kim et al.
CLINICAL IMAGING (2008)
Validation of the HCC-MELD for dropout probability in patients with small hepatocellular carcinoma undergoing locoregional therapy
Teh-Ia Huo et al.
CLINICAL TRANSPLANTATION (2008)
Contrast-enhanced ultrasound assessment of arterial vascularization of small nodules arising in the cirrhotic liver
M. Pompili et al.
DIGESTIVE AND LIVER DISEASE (2008)
Multicentre randomised phase III trial comparing tamoxifen alone or with transarterial lipiodol chemoembolisation for unresectable hepatocellular carcinoma in cirrhotic patients (federation francophone de cancerologie digestive 9402)
M. Doffoel et al.
EUROPEAN JOURNAL OF CANCER (2008)
Sorafenib in advanced hepatocellular carcinoma
Josep M. Llovet et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma
Alejandro Forner et al.
HEPATOLOGY (2008)
Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome? Seeding risk for percutaneous approach of HCC
R. Stigliano et al.
CANCER TREATMENT REVIEWS (2007)
The clinical outcome of small (<20 mm) arterially enhancing nodules on MRI in the cirrhotic liver
Valerie Byrnes et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
A prospective randomized trial comparing percutaneous local ablative therapy and partial hepatectomy for small hepatocellular carcinoma
MS Chen et al.
ANNALS OF SURGERY (2006)
Postoperative Transhepatic arterial chemoembolization and portal vein chemotherapy for patients with hepatocellular carcinoma: A randomized study with 131 cases
Q. Li et al.
DIGESTIVE SURGERY (2006)
Importance of small (≤20-mm) enhancing lesions seen only during the hepatic arterial phase at MR imaging of the cirrhotic liver:: Evaluation and comparison with whole explanted liver
AE Holland et al.
RADIOLOGY (2005)
Outcome of small (10-20 mm) arterial phase-enhancing nodules seen on triphasic liver CT in patients with cirrhosis or chronic liver disease
ME O'Malley et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2005)
Randomized controlled trial of screening for hepatocellular carcinoma
BH Zhang et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2004)
Evaluation of transcatheter arterial embolization prior to percutaneous tumor ablation in patients with hepatocellular carcinoma: a randomized controlled trial
M Akamatsu et al.
LIVER INTERNATIONAL (2004)
Hepatocellular carcinoma in cirrhosis: Incidence and risk factors
G Fattovich et al.
GASTROENTEROLOGY (2004)
A follow-up analysis of the pattern and predictors of dropout from the waiting list for liver transplantation in patients with hepatocellular carcinoma: Implications for the current organ allocation policy
FY Yao et al.
LIVER TRANSPLANTATION (2003)
Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival
JM Llovet et al.
HEPATOLOGY (2003)
Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma:: a randomised controlled trial
JM Llovet et al.
LANCET (2002)
Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma
CM Lo et al.
HEPATOLOGY (2002)
Chemoembolization improves survival in patients with unresectable hepatocellular carcinoma (HCC)
JM Llovet et al.
JOURNAL OF HEPATOLOGY (2001)
分享论文
